Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisAn integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesAlbuterol enantiomer levels, lung function and QTc interval in patients with acute severe asthma and COPD in the emergency department.Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.Differentiating COPD from asthma in clinical practice.Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.Safety, tolerability and risk benefit analysis of tiotropium in COPD.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NOReal-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort study.Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease.
P2860
Q24197853-B72BA8EB-4B48-4C6B-B5FD-E1B2817728EBQ33766956-17261035-CD91-49FF-AD43-5D507B023B43Q35102725-2BA22538-4661-432A-8A57-1556A5EC0F00Q35508561-5B478360-3605-47CD-95E4-89A4AA496DE5Q35538249-99546A1F-6EEF-470A-BAB1-24195D4A74B9Q35696088-45983B27-B5E2-4FD4-AAAC-50AAFD5B6EFAQ36951507-654387F3-6BB0-4FCB-AAFB-BCF9B2910388Q37017238-C4189222-D04D-415A-8BF6-EEC35476CE69Q37115876-49212A04-A91C-4AA6-B21F-D8B8595094A2Q37177278-944EB62E-E69A-4D1D-9444-B5B4F60B71E1Q37644823-441F45CE-A05A-4D30-AEBD-2021EC3C3E2BQ38630770-B7410835-68AB-4631-BC3A-BC8B9133594FQ42414640-559E861F-DEBC-4004-9FE7-DCD91333A915Q47648921-A773D21C-339C-4B92-A539-1963D10E28DBQ47964378-3F48DFDB-4CAC-4908-8114-BE1B611C155F
P2860
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease
@nl
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@ast
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@en
type
label
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease
@nl
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@ast
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@en
altLabel
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease
@en
prefLabel
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease
@nl
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@ast
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@en
P2093
P1476
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease
@en
Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
@en
P2093
P304
P356
10.1002/14651858.CD001495
P407
P577
2000-01-01T00:00:00Z
2002-01-01T00:00:00Z